Advertisement
Screener

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Interest and Other Income

3.0 / 5 stars · 48/80 Roast Me

BIOCRYST PHARMACEUTICALS, INC. Interest and Other Income

BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Interest and Other Income of $2.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Other Income

us-gaap:InterestAndOtherIncome · last filed 2026-08-05

  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for the quarter ending 2026-06-30 was $2.43M, a 3.26% decline year-over-year.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for the quarter ending 2026-03-31 was $2.26M, a 25.40% decline year-over-year.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for the quarter ending 2025-12-31 was $2.89M, a 19.05% decline year-over-year.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for the quarter ending 2025-09-30 was $2.24M, a 37.68% decline year-over-year.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for fiscal 2025 was $10.67M, a 27.65% decline from fiscal 2024.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for fiscal 2024 was $14.75M, a 6.53% decline from fiscal 2023.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for fiscal 2023 was $15.78M, a 207.72% increase from fiscal 2022.
  • BIOCRYST PHARMACEUTICALS, INC. interest and other income for fiscal 2022 was $5.13M.
Period endInterest and Other Income 3 monthInterest and Other Income 6 monthInterest and Other Income 9 monthInterest and Other Income 12 month
2026-06-30$2.43M
10-Q · filed 2026-08-05
$4.69M
10-Q · filed 2026-08-05
$7.58M
derived: sum of 3 quarters · filed 2026-08-05
$9.82M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$2.26M
10-Q · filed 2026-05-06
$5.15M
derived: sum of 2 quarters · filed 2026-05-06
$7.38M
derived: sum of 3 quarters · filed 2026-05-06
$9.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$2.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.13M
derived: sum of 2 quarters · filed 2026-02-26
$7.64M
derived: sum of 3 quarters · filed 2026-08-05
$10.67M
10-K · filed 2026-02-26
2025-09-30$2.24M
10-Q · filed 2025-11-04
$4.75M
derived: sum of 2 quarters · filed 2026-08-05
$7.78M
10-Q · filed 2025-11-04
$11.35M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$2.52M
10-Q · filed 2026-08-05
$5.54M
10-Q · filed 2026-08-05
$9.11M
derived: sum of 3 quarters · filed 2026-08-05
$12.70M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$3.02M
10-Q · filed 2026-05-06
$6.59M
derived: sum of 2 quarters · filed 2026-05-06
$10.19M
derived: sum of 3 quarters · filed 2026-05-06
$13.74M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$7.16M
derived: sum of 2 quarters · filed 2026-02-26
$10.71M
derived: sum of 3 quarters · filed 2026-02-26
$14.75M
10-K · filed 2026-02-26
2024-09-30$3.59M
10-Q · filed 2025-11-04
$7.14M
derived: sum of 2 quarters · filed 2025-11-04
$11.18M
10-Q · filed 2025-11-04
$15.64M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$3.55M
10-Q · filed 2025-08-05
$7.58M
10-Q · filed 2025-08-05
$12.05M
derived: sum of 3 quarters · filed 2026-02-26
$16.23M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$4.03M
10-Q · filed 2025-05-06
$8.50M
derived: sum of 2 quarters · filed 2026-02-26
$12.68M
derived: sum of 3 quarters · filed 2026-02-26
$16.43M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$4.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.65M
derived: sum of 2 quarters · filed 2026-02-26
$12.40M
derived: sum of 3 quarters · filed 2026-02-26
$15.78M
10-K · filed 2026-02-26
2023-09-30$4.18M
10-Q · filed 2024-11-05
$7.93M
derived: sum of 2 quarters · filed 2024-11-05
$11.31M
10-Q · filed 2024-11-05
2023-06-30$3.75M
10-Q · filed 2024-08-06
$7.13M
10-Q · filed 2024-08-06
2023-03-31$3.38M
10-Q · filed 2024-05-07
2022-12-31$5.13M
10-K · filed 2025-02-25
2020-06-30$2.76M
10-Q · filed 2020-08-07
$9.20M
10-Q · filed 2020-08-07
$9.59M
derived: sum of 3 quarters · filed 2020-08-07
$9.99M
derived: sum of 4 quarters · filed 2020-08-07
2020-03-31$6.45M
10-Q · filed 2020-05-11
$6.83M
derived: sum of 2 quarters · filed 2020-05-11
$7.24M
derived: sum of 3 quarters · filed 2020-05-11
$7.78M
derived: sum of 4 quarters · filed 2020-08-07
2019-12-31$388.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$790.00K
derived: sum of 2 quarters · filed 2020-03-13
$1.34M
derived: sum of 3 quarters · filed 2020-08-07
$1.93M
10-K · filed 2020-03-13
2019-09-30$402.00K
10-Q · filed 2019-11-08
$949.00K
derived: sum of 2 quarters · filed 2020-08-07
$1.54M
10-Q · filed 2019-11-08
$2.23M
derived: sum of 4 quarters · filed 2020-08-07
2019-06-30$547.00K
10-Q · filed 2020-08-07
$1.14M
10-Q · filed 2020-08-07
$1.83M
derived: sum of 3 quarters · filed 2020-08-07
$2.44M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31$596.00K
10-Q · filed 2020-05-11
$1.28M
derived: sum of 2 quarters · filed 2020-05-11
$1.89M
derived: sum of 3 quarters · filed 2020-05-11
$2.39M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$686.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$1.30M
derived: sum of 2 quarters · filed 2020-03-13
$1.79M
derived: sum of 3 quarters · filed 2020-03-13
$2.25M
10-K · filed 2020-03-13
2018-09-30$611.00K
10-Q · filed 2019-11-08
$1.10M
derived: sum of 2 quarters · filed 2019-11-08
$1.57M
10-Q · filed 2019-11-08
$2.04M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30$493.00K
10-Q · filed 2019-08-08
$955.00K
10-Q · filed 2019-08-08
$1.43M
derived: sum of 3 quarters · filed 2020-03-13
$1.66M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31$462.00K
10-Q · filed 2019-05-09
$940.00K
derived: sum of 2 quarters · filed 2020-03-13
$1.17M
derived: sum of 3 quarters · filed 2020-03-13
$1.37M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31$478.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$703.00K
derived: sum of 2 quarters · filed 2020-03-13
$906.00K
derived: sum of 3 quarters · filed 2020-03-13
$1.01M
10-K · filed 2020-03-13
2017-09-30$225.00K
10-Q · filed 2018-11-08
$428.00K
derived: sum of 2 quarters · filed 2018-11-08
$537.00K
10-Q · filed 2018-11-08
$635.00K
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30$203.00K
10-Q · filed 2018-08-09
$312.00K
10-Q · filed 2018-08-09
$410.00K
derived: sum of 3 quarters · filed 2019-03-14
$519.00K
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31$109.00K
10-Q · filed 2018-05-09
$207.00K
derived: sum of 2 quarters · filed 2019-03-14
$316.00K
derived: sum of 3 quarters · filed 2019-03-14
$463.00K
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31$98.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$207.00K
derived: sum of 2 quarters · filed 2019-03-14
$354.00K
derived: sum of 3 quarters · filed 2019-03-14
$793.00K
10-K · filed 2019-03-14
2016-09-30$109.00K
10-Q · filed 2017-11-08
$256.00K
derived: sum of 2 quarters · filed 2017-11-08
$695.00K
10-Q · filed 2017-11-08
$863.00K
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$147.00K
10-Q · filed 2017-08-08
$586.00K
10-Q · filed 2017-08-08
$754.00K
derived: sum of 3 quarters · filed 2018-03-12
$888.00K
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31$439.00K
10-Q · filed 2017-05-08
$607.00K
derived: sum of 2 quarters · filed 2018-03-12
$741.00K
derived: sum of 3 quarters · filed 2018-03-12
$857.00K
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$302.00K
derived: sum of 2 quarters · filed 2018-03-12
$418.00K
derived: sum of 3 quarters · filed 2018-03-12
$535.00K
10-K · filed 2018-03-12
2015-09-30$134.00K
10-Q · filed 2016-11-08
$250.00K
derived: sum of 2 quarters · filed 2016-11-08
$367.00K
10-Q · filed 2016-11-08
$410.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$116.00K
10-Q · filed 2016-08-08
$233.00K
10-Q · filed 2016-08-08
$276.00K
derived: sum of 3 quarters · filed 2017-02-27
$290.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$117.00K
10-Q · filed 2016-05-09
$160.00K
derived: sum of 2 quarters · filed 2017-02-27
$174.00K
derived: sum of 3 quarters · filed 2017-02-27
$193.00K
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$57.00K
derived: sum of 2 quarters · filed 2017-02-27
$76.00K
derived: sum of 3 quarters · filed 2017-02-27
$93.00K
10-K · filed 2017-02-27
2014-09-30$14.00K
10-Q · filed 2015-11-06
$33.00K
derived: sum of 2 quarters · filed 2015-11-06
$50.00K
10-Q · filed 2015-11-06
$71.00K
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$19.00K
10-Q · filed 2015-08-07
$36.00K
10-Q · filed 2015-08-07
$57.00K
derived: sum of 3 quarters · filed 2016-02-26
$75.00K
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$17.00K
10-Q · filed 2015-05-08
$38.00K
derived: sum of 2 quarters · filed 2016-02-26
$56.00K
derived: sum of 3 quarters · filed 2016-02-26
$77.00K
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$39.00K
derived: sum of 2 quarters · filed 2016-02-26
$60.00K
derived: sum of 3 quarters · filed 2016-02-26
$93.00K
10-K · filed 2016-02-26
2013-09-30$18.00K
10-Q · filed 2014-11-07
$39.00K
derived: sum of 2 quarters · filed 2014-11-07
$72.00K
10-Q · filed 2014-11-07
$112.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$21.00K
10-Q · filed 2014-08-08
$54.00K
10-Q · filed 2014-08-08
$94.00K
derived: sum of 3 quarters · filed 2015-03-02
$148.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$33.00K
10-Q · filed 2014-05-09
$73.00K
derived: sum of 2 quarters · filed 2015-03-02
$127.00K
derived: sum of 3 quarters · filed 2015-03-02
$184.00K
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$94.00K
derived: sum of 2 quarters · filed 2015-03-02
$151.00K
derived: sum of 3 quarters · filed 2015-03-02
$222.00K
10-K · filed 2015-03-02
2012-09-30$54.00K
10-Q · filed 2013-11-08
$111.00K
derived: sum of 2 quarters · filed 2013-11-08
$182.00K
10-Q · filed 2013-11-08
$266.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$57.00K
10-Q · filed 2013-08-08
$128.00K
10-Q · filed 2013-08-08
$212.00K
derived: sum of 3 quarters · filed 2014-03-10
$304.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31$71.00K
10-Q · filed 2013-05-09
$155.00K
derived: sum of 2 quarters · filed 2014-03-10
$247.00K
derived: sum of 3 quarters · filed 2014-03-10
$383.00K
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31$84.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$176.00K
derived: sum of 2 quarters · filed 2014-03-10
$312.00K
derived: sum of 3 quarters · filed 2014-03-10
$413.00K
10-K · filed 2014-03-10
2011-09-30$92.00K
10-Q · filed 2012-11-08
$228.00K
derived: sum of 2 quarters · filed 2012-11-08
$329.00K
10-Q · filed 2012-11-08
$437.00K
derived: sum of 4 quarters · filed 2013-03-11
2011-06-30$136.00K
10-Q · filed 2012-08-08
$239.00K
10-Q · filed 2012-08-08
$345.00K
derived: sum of 3 quarters · filed 2013-03-11
$471.00K
derived: sum of 4 quarters · filed 2013-03-11
2011-03-31$102.00K
10-Q · filed 2012-05-08
$209.00K
derived: sum of 2 quarters · filed 2013-03-11
$335.00K
derived: sum of 3 quarters · filed 2013-03-11
$472.00K
derived: sum of 4 quarters · filed 2013-03-11
2010-12-31$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$233.00K
derived: sum of 2 quarters · filed 2013-03-11
$370.00K
derived: sum of 3 quarters · filed 2013-03-11
$504.00K
10-K · filed 2013-03-11
2010-09-30$126.00K
10-Q · filed 2011-11-03
$263.00K
derived: sum of 2 quarters · filed 2011-11-03
$397.00K
10-Q · filed 2011-11-03
2010-06-30$137.00K
10-Q · filed 2011-08-04
$271.00K
10-Q · filed 2011-08-04
2009-12-31$286.00K
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43